Cisternography and Ventriculography Gadopentate Dimeglumine–Enhanced MR Imaging in Pediatric Patients: Preliminary Report

References

1. ↵
   Aydin K, Guven, Sencer S, et al. MRI cisternography with gadolinium-containing contrast medium: its role, advantages and limitations in the investigation of rhinorrhoea. Neuroradiology 2004;46:75–80. Epub 2003 Nov 13

   CrossRefPubMed
2. ↵
   Wenzel R, Leppien A. Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea. Neuroradiology 2000;42:874–80

   CrossRefPubMed
3. ↵
   Siebner HR, Gräfin von Einsiedel H, Conrad B, et al. Magnetic resonance ventriculography with gadolinium DTPA: report of two cases. Neuroradiology 1997;39:418–22

   CrossRefPubMed
4. ↵
   Zeng QY, Xiong L, Jinkins JR, et al. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients. AJR Am J Roentgenol 1999;173:1109–15

   PubMed
5. ↵
   Turgut TE, Ercan N, Kaymaz M, et al. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts. Neuroradiology 2004;46:744–54

   CrossRefPubMed
6. ↵
   Di Chiro G, Knop RH, Girton ME, et al. MR cisternography and myelography with gadolinium DTPA in monkeys. Radiology 1985;157:373–77

   PubMed
7. ↵
   Di Chiro G, Girton ME, Frank JA, et al. Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs. Radiology 1986;160:221–22

   PubMed
8. ↵
   Skalpe IO, Tang GJ. Magnetic resonance imaging contrast media in the subarachnoid space: a comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Invest Radiol 1997;32:140–48

   CrossRefPubMed
9. ↵
   Ibarra R, Jinkins JR, Korvick D, et al. Evaluation of intrathecal gadolinium-enhanced MR cisternography in a rabbit model of traumatic nasoethmoidal CSF fistula. J Magn Reson Imaging 2000;11:20–24

   CrossRefPubMed
10. ↵
    Morris TW, Ekholm SE, Prentice LJ. The effects of gadolinium-DTPA and –DOTA on neural tissue metabolism. Invest Radiol 1991;26:1087–90

    CrossRefPubMed
11. ↵
    Ray DE, Holton JL, Nolan CC, et al. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol 1998;19:1455–62

    Abstract
12. ↵
    Toney GM, Chavez HA, Ibarra R, et al. Acute and subacute physiologic and histologic studies of the central nervous system after intrathecal gadolinium injection in the anesthetized rat. Invest Radiol 2001;36:33–40

    PubMed
13. ↵
    Jinkins JR, Rudwan M, Krumina G, et al. Intrathecal gadolinium-enhanced MR cisternography in the evaluation of clinically suspected cerebrospinal fluid rhinorrhea in humans: early experience. Radiology 2002;222:555–59

    PubMedWeb of Science
14. ↵
    Zeng QY, Xiong L, Jinkins JR, et al. Intrathecal gadolinium-enhanced MR myelography: a pilot study in human patients (abstr). Presented at: Radiological Society of North America Scientific Program 1997; November 30–December 5, 1997; Chicago;1997;205(P):468
15. ↵
    Turgut TE, Ercan N, Krumina G, et al. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study. Invest Radiol 2002;37:152–59

    CrossRefPubMedWeb of Science
16. ↵
    Brash RC. Methods of contrast enhancement for NMR imaging and potential applications. Radiology 1983;147:781–88

    PubMedWeb of Science
17. ↵
    Rosen GM, Griffeth LK, Brown MA, et al. Intrathecal administration of nitroxides as potential contrast agents for MR imaging. Radiology 1987;163:239–43

    PubMed
18. ↵
    Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of gadolinium DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619–24

    PubMedWeb of Science
19. ↵
    Hinshaw DB, Wong VC. Paramagnetic contrast agents in the evaluation of brain neoplasms. Top Magn Reson Imaging 1989;1:79–93

    PubMed
20. ↵
    Saini S. Advances in contrast-enhanced MR imaging: principles. AJR Am J Roentgenol 1991;156:236–39

    PubMed
21. ↵
    Hegarty SE, Millar JS. MRI in the localization of CSF fistulae: is it of any value? Clin Radiol 1997;52:768–70

    CrossRefPubMed